home About Us People Portfolio Contact Us Fund II Investor Login » Fund III Investor Login » Fund IV Investor Login » Fund V Investor Log In »

Outset Medical

$35 million

Medical Device
Nephrology

Outset Medical, Inc. is a rapidly growing medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. Its Tablo® Hemodialysis System (Tablo) represents a significant technological advancement enabling novel, transformational dialysis care in acute and home settings. Tablo was designed from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone.